cholestyramine resin has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Du, Y; Lin, J; Si, D; Tian, X; Wang, S; Wang, Z; Yang, Y; Zhang, J; Zhang, X; Zhang, Y | 1 |
| Honda, Y; Imajo, K; Iwaki, M; Kasai, Y; Kessoku, T; Kobayashi, N; Kobayashi, T; Nakajima, A; Nogami, A; Ogawa, Y; Ozaki, A; Saito, S; Tanaka, K; Usuda, H; Wada, K; Yoneda, M | 1 |
| Honda, Y; Imajo, K; Iwaki, M; Kessoku, T; Kobayashi, T; Nakajima, A; Ogawa, Y; Ozaki, A; Saigusa, Y; Saito, S; Usuda, H; Wada, K; Yamamoto, K; Yamanaka, T; Yoneda, M | 1 |
| Alegado, RA; Chen, W; Ge, K; Huang, F; Ji, J; Jia, W; Jiang, R; Lei, S; Liu, J; Liu, P; Nicholson, J; Rajani, C; Wang, X; Xie, G; Yan, J; Zhang, Y; Zhao, A; Zheng, X | 1 |
4 other study(ies) available for cholestyramine resin and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Integration of Metabolomics, Lipidomics, and Proteomics Reveals the Metabolic Characterization of Nonalcoholic Steatohepatitis.
Topics: Animals; Cholestyramine Resin; Lipidomics; Liver; Metabolomics; Mice; Non-alcoholic Fatty Liver Disease; Proteomics | 2023 |
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.
Topics: Animals; Atherosclerosis; Bile Acids and Salts; Carcinogenesis; Cholestyramine Resin; Disease Models, Animal; Mice; Non-alcoholic Fatty Liver Disease | 2023 |
Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease.
Topics: Adult; Cholestyramine Resin; Clinical Trials, Phase II as Topic; Dipeptides; Double-Blind Method; Humans; Non-alcoholic Fatty Liver Disease; Proof of Concept Study; Randomized Controlled Trials as Topic; Thiazepines | 2020 |
Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes.
Topics: Animals; Bacteria; Bile Acids and Salts; Carcinoma, Hepatocellular; Cholestyramine Resin; Diet, High-Fat; Disease Models, Animal; Female; Gastrointestinal Microbiome; Gene Expression Regulation, Neoplastic; Humans; Incidence; Liver Neoplasms; Male; Metagenomics; Mice; MicroRNAs; Non-alcoholic Fatty Liver Disease; Sex Factors; Streptozocin | 2017 |